Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Free Cash Flow: 2015-2024

Historic Free Cash Flow for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Dec 2024 value amounting to -$113.9 million.

  • Rhythm Pharmaceuticals' Free Cash Flow fell 5.58% to -$26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.1 million, marking a year-over-year increase of 12.29%. This contributed to the annual value of -$113.9 million for FY2024, which is 16.39% up from last year.
  • Rhythm Pharmaceuticals' Free Cash Flow amounted to -$113.9 million in FY2024, which was up 16.39% from -$136.2 million recorded in FY2023.
  • Rhythm Pharmaceuticals' Free Cash Flow's 5-year high stood at -$113.9 million during FY2024, with a 5-year trough of -$173.7 million in FY2022.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Free Cash Flow value was -$136.2 million (recorded in 2023), while the average stood at -$141.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first decreased by 19.84% in 2021, then grew by 21.59% in 2023.
  • Yearly analysis of 5 years shows Rhythm Pharmaceuticals' Free Cash Flow stood at -$122.2 million in 2020, then declined by 19.84% to -$146.4 million in 2021, then decreased by 18.62% to -$173.7 million in 2022, then climbed by 21.59% to -$136.2 million in 2023, then climbed by 16.39% to -$113.9 million in 2024.